Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
This combination of Parkinsonism and polytrauma provides a powerful example of how neurodegeneration can be compounded by structural damage, with each element worsening the other.
Geriatrics August 20th 2025
Medical Professionals Reference (MPR)
This breakthrough in noninvasive, intelligent, and personalized neuromodulation marks the emergence of AI therapeutics in disease treatment.
Neurology July 23rd 2025
Parkinson’s News Today
Blood-based mitochondrial DNA testing could provide a less invasive alternative to spinal taps for Parkinson’s diagnosis, with implications for earlier intervention and treatment.
Allergy & Immunology January 22nd 2025
Neurology Learning Network
Long-term use of dopaminergic medications shows correlation with gradual RLS symptom deterioration, prompting a shift toward alpha-2-delta ligand calcium channel blockers as preferred pharmacological interventions.
Family Medicine/General Practice January 8th 2025
Psych Congress Network
Anticholinergic medications require careful consideration of both peripheral and central effects, particularly in patients with existing cognitive impairments.
Family Medicine/General Practice December 11th 2024
British Medical Journal (The BMJ)
Recent studies indicate that balance impairments are present in all essential tremor patients, though younger patients may employ compensatory mechanisms to perform better in clinical tests.
Neurology November 20th 2024